Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06179290 · ClinicalTrials.gov registry record · NA
Changes in Biomarker of Exposure in Adults Who Smoke Cigarettes Switching From Cigarettes to Heated Tobacco Products
A NA study of Tobacco Use, sponsored by Altria Client Services.
- Completed
- Registry status
- NA
- Development phase
- 921
- Enrollment target
- 7
- Study locations
NCT06179290 is a NA study of Tobacco Use that has completed, run by Altria Client Services. The registered enrollment target is 921 participants, above the 367-participant average among 76 other Tobacco Use trials with a reported enrollment target (151% higher). The trial reports 7 study locations across 7 states.
The verdict
NCT06179290, a NA study of Tobacco Use, has completed, sponsored by Altria Client Services.
- COMPLETED
- Registry status
- NA
- Development phase
- 921 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of the study is to evaluate changes in biomarkers of exposure (BoE) to harmful and potentially harmful constituents (HPHCs) in adult smokers who completely switch to Ploom heated tobacco products (HTPs) compared to those who continue to smoke usual brand combustible cigarettes (UBCC).
Conditions Studied
Interventions
- OTHER Ploom HTP Menthol HTS; MX3 (681)
- OTHER Ploom HTP Tobacco HTS; R8 (120)
- OTHER Smoking Abstinence (menthol)
- OTHER Smoking Abstinence (non-menthol)
Study Locations (7)
Arkansas
- Woodland Research Northwest - Rogers
Kansas
- Dr. Vince Clinical Research, LLC - Overland Park
Kentucky
- Alliance for Multispecialty Research, LLC - Lexington
Missouri
- QPS Bio-Kinetic - Springfield
Nebraska
- Celerion Lincoln - Lincoln
Tennessee
- Alliance for Multispecialty Research, LLC - Knoxville
Wisconsin
- Spaulding Clinical Research - West Bend
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 921 participants |
| Start Date | 2023-10-02 |
| Est. Completion | 2025-03-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06179290
The ClinicalTrials.gov registry entry for NCT06179290 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 921 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 367-participant average among 76 other Tobacco Use trials with a reported enrollment target (151% higher). The listed sponsor is Altria Client Services, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tobacco Use appearing as the primary indexed condition, and to 4 interventions - of which Ploom HTP Menthol HTS; MX3 (681) is the first listed.
NCT06179290 reports 7 study locations spanning 7 distinct geographic areas - top geographies include Arkansas, Kansas, Kentucky.
Frequently Asked Questions
What is clinical trial NCT06179290 about?
NCT06179290 is a clinical study titled "Changes in Biomarker of Exposure in Adults Who Smoke Cigarettes Switching From Cigarettes to Heated Tobacco Products". The purpose of the study is to evaluate changes in biomarkers of exposure (BoE) to harmful and potentially harmful constituents (HPHCs) in adult smokers who completely switch to Ploom heated tobacco products (HTPs) compared to those who continue to smoke usual brand combustible cigarettes (UBCC).
What is the current status of trial NCT06179290?
This trial is currently completed. It is a NA study. The enrollment target is 921 participants. The study started on 2023-10-02. Estimated completion is 2025-03-24.
What conditions does trial NCT06179290 study?
This clinical trial studies the following conditions: Tobacco Use.
What interventions are being tested in trial NCT06179290?
The interventions under investigation include: Ploom HTP Menthol HTS; MX3 (681) (OTHER), Ploom HTP Tobacco HTS; R8 (120) (OTHER), Smoking Abstinence (menthol) (OTHER), Smoking Abstinence (non-menthol) (OTHER).
Who is sponsoring clinical trial NCT06179290?
This trial is sponsored by Altria Client Services, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06179290 being conducted?
This trial has 7 study locations across Arkansas, Kansas, Kentucky, Missouri, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
-
Opioids, Low Nicotine Cigarettes, and Chronic Pain
RECRUITING · NA
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
-
RTMS Targets Neural Circuits for Smoking Cessation
RECRUITING · NA
-
Cigar Legislation and Regulation in Tobacco for the Young (Project CLARITY)
RECRUITING · NA
-
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.